Skip to content

ΕτικέταAbbVie

Dermavant Bags GSK Phase III-Ready Psoriasis Treatment in $330 Million Deal

  Months after tapping GlaxoSmithKline dermatology division executive David Rubenstein as its new chief scientific officer, Vivek Ramaswamy’s Dermavant Sciences has returned to the pharma giant to acquire a Phase III-ready psoriasis treatment. Unlike past moves where … Continue Reading Dermavant Bags GSK Phase III-Ready Psoriasis Treatment in $330 Million Deal